Jubilant Biosys Limited
www.jubilantbiosys.comJubilant Biosys Ltd (JBL) offers services in Structural Biology, Computational Chemistry, Medicinal Chemistry, in-vitro and in-vivo Biology, DMPK and Toxicology areas to various pharmaceutical and biotechnology. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Life Sciences (a $1.3 Bn Sales Corporation) providing innovative drug discovery services to the global life sciences, agrochemicals and specialty chemicals industry through its research centers in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain, Inflammation, Fibrosis and Respiratory diseases. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.
Read moreJubilant Biosys Ltd (JBL) offers services in Structural Biology, Computational Chemistry, Medicinal Chemistry, in-vitro and in-vivo Biology, DMPK and Toxicology areas to various pharmaceutical and biotechnology. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Life Sciences (a $1.3 Bn Sales Corporation) providing innovative drug discovery services to the global life sciences, agrochemicals and specialty chemicals industry through its research centers in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain, Inflammation, Fibrosis and Respiratory diseases. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.
Read moreCountry
City (Headquarters)
Noida
Industry
Employees
501-1000
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Associate Vice President
Email ****** @****.comPhone (***) ****-****Human Resources Business Partner , Deputy Manager Human Resources
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Director - Dmpk
Email ****** @****.comPhone (***) ****-****
Technologies
(57)